The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Open accessAbstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA. METHODS: We enrolled adult patients with acute, purulent skin and soft-tissue infections presenting to 11 university-affiliated emergency departments during the month of August 2004. Cultures were obtained, and clinical information was collected. Available S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel electrophoresis, and detection of toxin genes. On MRSA isolates, we performed typing of the staphylococcal cassette chromosome mec (SCCmec), the genetic element that carries the mecA gene encoding methicillin resistance. RESULTS: S. aureus was isolated from 320 of 422 patients with skin and soft-tissue infections (76 percent). The prevalence of MRSA was 59 percent overall and ranged from 15 to 74 percent. Pulsed-field type USA300 isolates accounted for 97 percent of MRSA isolates; 74 percent of these were a single strain (USA300-0114). SCCmec type IV and the Panton-Valentine leukocidin toxin gene were detected in 98 percent of MRSA isolates. Other toxin genes were detected rarely. Among the MRSA isolates, 95 percent were susceptible to clindamycin, 6 percent to erythromycin, 60 percent to fluoroquinolones, 100 percent to rifampin and trimethoprim-sulfamethoxazole, and 92 percent to tetracycline. Antibiotic therapy was not concordant with the results of susceptibility testing in 100 of 175 patients with MRSA infection who received antibiotics (57 percent). Among methicillin-susceptible S. aureus isolates, 31 percent were USA300 and 42 percent contained pvl genes. CONCLUSIONS: MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recently published study of 422 patients with SSTI from 11 EDs in the United States reported that the prevalence of MRSA was 59%. 15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“In other research, IDU was strongly linked to MRSA SSTI in homeless individuals, 7 but this association was not found in 2 ED-based studies. 8,15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Self-citationA Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Self-citationFrancis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., Cai, M., Hansel, N. N., Perl, T., Ticehurst, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 719
Barrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., & Knirsch, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2260-2266.2005 · Cited by 457
Research works printed but not linked: 3
- 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- Bannerman TL. Staphylococci and other catalase positive cocci that grow aerobically. In: Murray PR, Baron EJ, Jogensen JH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:384-404.
- 10.1097/00006454-200307000-00006 · doi:10.1097/00006454-200307000-00006
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citationKlevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Methicillin-resistant Staphylococcus aureus
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,556
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Self-citationA Review of the Research Literature on Evidence-Based Healthcare Design
Ulrich, R. S., Zimring, C., Zhu, X., DuBose, J., Seo, H.-B., Choi, Y.-S., Quan, X., & Joseph, A. (2008) · HERD: Health Environments Research & Design Journal · doi:10.1177/193758670800100306 · Cited by 1,421
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H., & Pringle, M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-13 · Cited by 1,262
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
Monecke, S., Coombs, G., Shore, A. C., Coleman, D. C., Akpaka, P., Borg, M., Chow, H., Ip, M., Jatzwauk, L., Jonas, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017936 · Cited by 947
Gorwitz, R. J., Kruszon‐Moran, D., McAllister, S. K., McQuillan, G., McDougal, L. K., Fosheim, G. E., Jensen, B. J., Killgore, G., Tenover, F. C., & Kuehnert, M. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/533494 · Cited by 926
Self-citationKlein, E., Smith, D. L., & Laxminarayan, R. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1312.070629 · Cited by 862
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Epidemiology of Methicillin‐Resistant Staphylococcus aureus
Boucher, H. W., & Corey, G. R. (2008) · Clinical Infectious Diseases · doi:10.1086/533590 · Cited by 805
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
The evolution of Staphylococcus aureus
Deurenberg, R. H., & Stobberingh, E. E. (2008) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2008.07.007 · Cited by 721
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
van der Poll, T., & Opal, S. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61114-4 · Cited by 720
How Staphylococcus aureus biofilms develop their characteristic structure
Periasamy, S., Joo, H.-S., Duong, A. C., Bach, T.-H. L., Tan, V. Y., Chatterjee, S. S., Cheung, G. Y. C., & Otto, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115006109 · Cited by 640
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658
Bacteriophage therapy: a potential solution for the antibiotic resistance crisis
Golkar, Z., Bagasra, O., & Pace, D. G. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3573 · Cited by 593
Stefani, S., Chung, D. R., Lindsay, J. A., Friedrich, A. W., Kearns, A. M., Westh, H., & MacKenzie, F. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.030 · Cited by 590
Cock, I., Cheesman, M., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews · doi:10.4103/phrev.phrev_21_17 · Cited by 550
Harris, S. R., Cartwright, E. J., Török, M. E., Holden, M. T., Brown, N. M., Ogilvy-Stuart, A. L., Ellington, M. J., Quail, M. A., Bentley, S. D., Parkhill, J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70268-2 · Cited by 564
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 553
Boyle-Vavra, S., & Daum, R. S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700501 · Cited by 538
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 512
Citron, D. M., Goldstein, E. J. C., Merriam, C. V., Lipsky, B. A., & Abramson, M. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00551-07 · Cited by 509
Shao, Y., Wang, Y., Yuan, Y., & Xie, Y. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149205 · Cited by 492
National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft-Tissue Infections
Hersh, A. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1585 · Cited by 501
Shallcross, L. J., Fragaszy, E., Johnson, A. M., & Hayward, A. C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70238-4 · Cited by 463
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 466
Raff, A. B., & Kroshinsky, D. (2016) · JAMA · doi:10.1001/jama.2016.8825 · Cited by 452
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology
Tenover, F. C., & Goering, R. V. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp241 · Cited by 441
Peptide Signaling in the Staphylococci
Thoendel, M., Kavanaugh, J. S., Flack, C. E., & Horswill, A. R. (2011) · Chemical Reviews · doi:10.1021/cr100370n · Cited by 438
Pallin, D. J., Egan, D. J., Pelletier, A. J., Espinola, J. A., Hooper, D. C., & Camargo, C. A. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.12.004 · Cited by 447
Craven, R. R., Gao, X., Allen, I. C., Gris, D., Wardenburg, J. B., McElvania-TeKippe, E., Ting, J. P., & Duncan, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007446 · Cited by 433
Boedicker, J. Q., Li, L., Kline, T. R., & Ismagilov, R. F. (2008) · Lab on a Chip · doi:10.1039/b804911d · Cited by 438
Health Care–Associated Invasive MRSA Infections, 2005-2008
Kallen, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1115 · Cited by 439
Immunity against Staphylococcus aureus cutaneous infections
Miller, L. S., & Cho, J. S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3010 · Cited by 434
Diep, B. A., Stone, G. G., Basuino, L., Graber, C. J., Miller, A., Etages, S. D., Jones, A., Palazzolo‐Ballance, A. M., Perdreau‐Remington, F., Sensabaugh, G. F., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587907 · Cited by 422
Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus
Daum, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070747 · Cited by 417
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe
Otter, J. A., & French, G. L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70053-0 · Cited by 398
Tristan, A., Bes, M., Meugnier, H., Lina, G., Bozdogan, B., Courvalin, P., Reverdy, M.-E., Enright, M. C., Vandenesch, F., & Etienne, J. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1304.061316 · Cited by 410
Neutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., Chambers, H. F., Lu, Y., & Otto, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900743106 · Cited by 394
Diep, B. A., Chambers, H. F., Graber, C. J., Szumowski, J. D., Miller, L. G., Han, L. L., Chen, J. H., Lin, F., Lin, J., Phan, T. H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00204 · Cited by 391
Self-citationKennedy, A. D., Otto, M., Braughton, K. R., Whitney, A. R., Chen, L., Mathema, B., Mediavilla, J. R., Byrne, K. A., Parkins, L. D., Tenover, F. C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710217105 · Cited by 387
Pathogenesis of Staphylococcus aureus Abscesses
Kobayashi, S. D., Malachowa, N., & DeLeo, F. R. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.11.030 · Cited by 351
Popovich, K. J., Weinstein, R. A., & Hota, B. (2008) · Clinical Infectious Diseases · doi:10.1086/528716 · Cited by 378
Community-associated MRSA: What makes them special?
Otto, M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.007 · Cited by 379
Complicated skin and soft tissue infection
Dryden, M. S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq302 · Cited by 366
Global Survey of Antibiotic Resistance Genes in Air
Li, J., Cao, J., Zhu, Y.-G., Chen, Q.-L., Shen, F., Wu, Y., Xu, S., Fan, H., Da, G., Huang, R.-J., et al. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b02204 · Cited by 371
Infection Control and Hospital Epidemiology: A Growth Opportunity in Medicine
Anderson, D. J., & Sexton, D. J. (2007) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31803c7c08 · Cited by 371
Mechanisms of Antibiotic Resistance in Staphylococcus Aureus
Pantosti, A., Sanchini, A., & Monaco, M. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.323 · Cited by 348
Maree, C. L., Daum, R. S., Boyle-Vavra, S., Matayoshi, K., & Miller, L. G. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1302.060781 · Cited by 333
Kennedy, A. D., Wardenburg, J. B., Gardner, D. J., Long, D., Whitney, A. R., Braughton, K. R., Schneewind, O., & DeLeo, F. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/656043 · Cited by 335
“Although the pathogen can cause severe or fatal invasive disease [26,27], the vast majority of USA300 infections are those of skin and soft tissue [28,29].”
BackgroundThe role of virulence determinants in community-associated MRSA pathogenesis
Diep, B. A., & Otto, M. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.05.002 · Cited by 328
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Stryjewski, M. E., & Corey, G. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit613 · Cited by 334
Cheung, G. Y. C., Wang, R., Khan, B. A., Sturdevant, D. E., & Otto, M. (2011) · Infection and Immunity · doi:10.1128/iai.00046-11 · Cited by 319
Trends in US Hospital Admissions for Skin and Soft Tissue Infections
Edelsberg, J., Taneja, C., Zervos, M., Haque, N., Moore, C., Reyes, K., Spalding, J., Jiang, J., & Oster, G. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.081228 · Cited by 326
Miller, L. S., Pietras, E. M., Uricchio, L. H., Hirano, K., Rao, S., Lin, H., O’Connell, R. M., Iwakura, Y., Cheung, A. L., Cheng, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6933 · Cited by 325
Miller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318
Staphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory Care
McCaig, L. F., McDonald, L. C., Mandal, S., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.060190 · Cited by 307
Finelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1336 · Cited by 312
Self-citationThe antimicrobial peptide‐sensing system aps of Staphylococcus aureus
Li, M., Cha, D. J., Lai, Y., Villaruz, A. E., Sturdevant, D. E., & Otto, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05986.x · Cited by 297
History of Antibiotics. From Salvarsan to Cephalosporins
Zaffiri, L., Gardner, J., & Toledo-Pereyra, L. H. (2012) · Journal of Investigative Surgery · doi:10.3109/08941939.2012.664099 · Cited by 260
Talan, D. A., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., Limbago, B., Albrecht, V., Moran, G. J., & for The EMERGEncy ID Net Study Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir308 · Cited by 300
Self-citationThe Clinical and Prognostic Importance of Positive Blood Cultures in Adults
Pien, B. C., Sundaram, P., Raoof, N., Costa, S. F., Mirrett, S., Woods, C. W., Reller, L. B., & Weinstein, M. P. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.03.021 · Cited by 293
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Cassir, N., Rolain, J.-M., & Brouqui, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00551 · Cited by 280
Ray, G. T., Suaya, J. A., & Baxter, R. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-252 · Cited by 281
Stryjewski, M. E., Graham, D. R., Wilson, S. E., O’Riordan, W., Young, D., Lentnek, A., Ross, D. P., Fowler, V. G., Hopkins, A., Friedland, H. D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587896 · Cited by 289
Commensal Staphylococci Influence Staphylococcus aureus Skin Colonization and Disease
Parlet, C. P., Brown, M. M., & Horswill, A. R. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.01.008 · Cited by 276
Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power
de Lencastre, H., Oliveira, D., & Tomasz, A. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.08.003 · Cited by 278
MRSA epidemic linked to a quickly spreading colonization and virulence determinant
Li, M., Du, X., Villaruz, A. E., Diep, B. A., Wang, D., Song, Y., Tian, Y., Hu, J., Yu, F., Lu, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2692 · Cited by 278
Stryjewski, M. E., & Chambers, H. F. (2008) · Clinical Infectious Diseases · doi:10.1086/533593 · Cited by 268
The continuing crisis in antibiotic resistance
French, G. L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(10)70003-0 · Cited by 271
Increasing Antibiotic Resistance among Methicillin‐Resistant Staphylococcus aureus Strains
Sakoulas, G., & Moellering, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/533592 · Cited by 274
Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation
Versey, Z., da Cruz Nizer, W. S., Russell, E., Zigic, S., DeZeeuw, K. G., Marek, J. E., Overhage, J., & Cassol, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648554 · Cited by 253
Noel, G. J., Bush, K., Bagchi, P., Ianus, J., & Strauss, R. S. (2008) · Clinical Infectious Diseases · doi:10.1086/526527 · Cited by 270
Kobayashi, S. D., Malachowa, N., Whitney, A. R., Braughton, K. R., Gardner, D. J., Long, D., Wardenburg, J. B., Schneewind, O., Otto, M., & DeLeo, F. R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir441 · Cited by 266
Host defense and pathogenesis in Staphylococcus aureus infections
DeLeo, F. R., Diep, B. A., & Otto, M. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.003 · Cited by 269
“Historically, CA S aureus infections almost always were caused by methicillin-susceptible S aureus (MSSA) rather than MRSA,(4) but this distribution has changed dramatically in the United States over the past 10 years.(6) Two reports in the late 1990s marked the beginning of a new era in MRSA epidemiology.”
BackgroundMethodKebaier, C., Chamberland, R. R., Allen, I. C., Gao, X., Broglie, P. M., Hall, J. D., Jania, C., Doerschuk, C. M., Tilley, S. L., & Duncan, J. A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir846 · Cited by 257
Highlander, S. K., Hultén, K. G., Qin, X., Jiang, H., Yerrapragada, S., Mason, E. O., Shang, Y., Williams, T. M., Fortunov, R. M., Liu, Y., et al. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-99 · Cited by 262
Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus
VANBELKUM, A., MELLES, D., NOUWEN, J., VANLEEUWEN, W., VANWAMEL, W., VOS, M., WERTHEIM, H., & VERBRUGH, H. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2008.09.012 · Cited by 251
Surgical site infections after cesarean delivery: epidemiology, prevention and treatment
Kawakita, T., & Landy, H. J. (2017) · Maternal Health, Neonatology and Perinatology · doi:10.1186/s40748-017-0051-3 · Cited by 237
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
Wolters, M., Rohde, H., Maier, T., Belmar-Campos, C., Franke, G., Scherpe, S., Aepfelbacher, M., & Christner, M. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.06.002 · Cited by 247
Metadata
- Authors
- Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A.
- Affiliations
- Olive View-UCLA Medical Center (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-08-17
- Volume
- 355
- Issue
- 7
- Pages
- 666-674
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131316809
- Cited by
- 2,285
- References
- 35
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 58 · 2023: 39 · 2022: 42 · 2021: 55 · 2020: 57 · 2019: 76 · 2018: 83 · 2017: 72 · 2016: 93 · 2015: 125 · 2014: 117 · 2013: 145 · 2012: 170
- FWCI
- 138.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (U01CI000353)
- U.S. Public Health Service (U50/CCU912342)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, emergency department patients, community-acquired MRSA, USA300, Panton-Valentine leukocidin, antibiotic susceptibility, empirical antibiotic therapy, antimicrobial resistance, methicillin-susceptible Staphylococcus aureus
- MeSH terms
- Acute Disease, Adult, Aged, Anti-Bacterial Agents, Bacterial Proteins, Bacterial Toxins, Emergency Service, Hospital, Exotoxins, Female, Humans, Leukocidins, Male, Microbial Sensitivity Tests, Middle Aged, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, United States, Methicillin Resistance, Electrophoresis, Gel, Pulsed-Field, Soft Tissue Infections, Penicillin-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.